Prexton Therapeutics Competitors and Similar CompaniesClear all
Prexton Therapeutics's competitors and similar companies include MorphoSys, Pyxant Labs, Prometheus Biosciences and Opko Health.
 Prexton Therapeutics Prexton Therapeutics applies a new scientific approach that fully integrates molecular, behavioural and chemistry technologies to address Parkinson’s disease and other brain disorders. |  MorphoSys MorphoSys is a biotechnology company focused on the research and development of fully human antibodies. |  Prometheus Biosciences Prometheus Biosciences (formerly known as Precision IBD) is a biopharmaceutical company committed to the discovery, development, and commercialization of therapeutics and diagnostics for patients with gastroenterology and autoimmune diseases. |  Opko Health Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics. | ||
Founding Date | Founding Date 2012 | Founding Date 1992 | Founding Date 2000 | Founding Date 1995 | Founding Date 2007 |
Type | Type Subsidiary | Type Subsidiary | Type Private | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Oss, NL HQ Plan Les Ouates, CH | Locations Planegg, DE HQ Boston, US | Locations Colorado Springs, US HQ Millcreek, US | Locations San Diego, US HQ | Locations Miami, US HQ Woburn, US |
Employees | Employees 1 | Employees 464 | Employees 1221% decrease | Employees 9735% increase | Employees 6,0967% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €238.3m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) $6.8m (FY, 2022) | Revenue (est.) $606.9m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods €34.6m (FY, 2023) | Cost of goods N/A | Cost of goods N/A | Cost of goods $400.9m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit €205.5m (FY, 2023) | Gross profit N/A | Gross profit N/A | Gross profit $205.9m (FY, 2025) |
Net income | Net income N/A | Net income (€189.7m) (FY, 2023) | Net income N/A | Net income ($141.8m) (FY, 2022) | Net income ($225.7m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 41.1m | Total funding raised $ 126m | Total funding raised $ 530k | Total funding raised $ 130m | Total funding raised $ 31m |
For sources of this data, please see the company profile
View Company Profiles
MorphoSys
HQ
Planegg, DE
MorphoSys is a biotechnology company focused on the research and development of fully human antibodies.
View company
Pyxant Labs
HQ
Colorado Springs, US
Employees
122↓ 1% decrease
Pyxant Labs is a company operating as a bioanalytical laboratory.
View companyPrometheus Biosciences
HQ
San Diego, US
Prometheus Biosciences (formerly known as Precision IBD) is a biopharmaceutical company committed to the discovery, development, and commercialization of therapeutics and diagnostics for patients with gastroenterology and autoimmune diseases.
View companyOpko Health
HQ
Miami, US
Employees
6,096↑ 7% increase
Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics.
View company